tiprankstipranks
Trending News
More News >
Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO
US Market
Advertisement

Northwest Biotherapeutics (NWBO) Ratios

Compare
524 Followers

Northwest Biotherapeutics Ratios

NWBO's free cash flow for Q2 2025 was $1.00. For the 2025 fiscal year, NWBO's free cash flow was decreased by $ and operating cash flow was $-103.45. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.07 0.09 0.07 0.13 0.04
Quick Ratio
0.07 0.09 0.07 0.13 0.04
Cash Ratio
0.05 0.05 0.06 0.11 0.03
Solvency Ratio
-0.62 -0.81 -0.85 1.09 -1.36
Operating Cash Flow Ratio
-0.53 -1.19 -0.42 -0.29 -0.08
Short-Term Operating Cash Flow Coverage
-1.07 -2.62 -3.32 -5.07 -4.99
Net Current Asset Value
$ -123.78M$ -70.80M$ -150.00M$ -146.86M$ -380.34M
Leverage Ratios
Debt-to-Assets Ratio
2.36 1.64 0.84 0.94 0.60
Debt-to-Equity Ratio
-0.70 -0.97 -0.20 -0.31 -0.05
Debt-to-Capital Ratio
-2.28 -32.18 -0.26 -0.44 -0.06
Long-Term Debt-to-Capital Ratio
-0.30 -0.76 -0.05 -0.25 -0.02
Financial Leverage Ratio
-0.29 -0.59 -0.24 -0.32 -0.09
Debt Service Coverage Ratio
-1.45 -2.15 -5.88 14.35 -35.34
Interest Coverage Ratio
-8.18 -10.59 -11.07 -10.52 -10.14
Debt to Market Cap
0.18 0.05 0.03 0.05 0.01
Interest Debt Per Share
0.05 0.05 0.03 0.05 0.04
Net Debt to EBITDA
-0.91 -0.78 -0.20 0.12 -0.02
Profitability Margins
Gross Profit Margin
100.00%-1335.30%8.02%-1920.70%-2505.50%
EBIT Margin
-6793.60%-2954.04%-5880.21%18322.09%-40377.77%
EBITDA Margin
-6613.53%-2864.34%-5788.24%18380.40%-40344.85%
Operating Profit Margin
-5977.15%-2873.08%-3991.74%-5243.98%-6708.37%
Pretax Profit Margin
-7548.72%-3240.11%-6240.76%17823.48%-41039.58%
Net Profit Margin
-7548.72%-3240.11%-8131.19%17823.48%-41701.39%
Continuous Operations Profit Margin
-7524.50%-3240.11%-6240.76%17823.48%-41039.58%
Net Income Per EBT
100.00%100.00%130.29%100.00%101.61%
EBT Per EBIT
126.29%112.77%156.34%-339.88%611.77%
Return on Assets (ROA)
-279.50%-224.65%-436.89%446.03%-1636.42%
Return on Equity (ROE)
92.12%133.26%106.83%-144.47%148.33%
Return on Capital Employed (ROCE)
120.26%320.13%70.95%56.30%24.78%
Return on Invested Capital (ROIC)
539.17%-1606.60%111.60%59.97%25.66%
Return on Tangible Assets
-298.90%-241.26%-465.39%468.40%-1737.73%
Earnings Yield
-23.25%-7.93%-17.17%29.29%-48.53%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.00 2.01 0.09 1.86 2.64
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.05 0.09 0.09 0.05 0.09
Asset Turnover
0.04 0.07 0.05 0.03 0.04
Working Capital Turnover Ratio
-0.01 -0.02 -0.01 >-0.01 >-0.01
Cash Conversion Cycle
0.00 -181.49 -4.16K -196.75 -138.28
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 181.49 4.16K 196.75 138.28
Operating Cycle
0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.03 -0.05 -0.05 -0.04 -0.04
Free Cash Flow Per Share
-0.03 -0.05 -0.05 -0.05 -0.05
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.01 1.06 1.05 1.16 1.21
Dividend Paid and CapEx Coverage Ratio
-29.04 -15.61 -18.19 -6.37 -4.86
Capital Expenditure Coverage Ratio
-68.39 -15.61 -18.19 -6.37 -4.86
Operating Cash Flow Coverage Ratio
-0.64 -1.18 -2.01 -1.01 -1.62
Operating Cash Flow to Sales Ratio
-40.69 -27.76 -31.36 -38.11 -24.86
Free Cash Flow Yield
-12.69%-7.23%-6.99%-7.25%-3.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.30 -12.61 -5.82 3.41 -2.06
Price-to-Sales (P/S) Ratio
324.82 408.63 473.52 608.42 859.37
Price-to-Book (P/B) Ratio
-3.54 -16.81 -6.22 -4.93 -3.06
Price-to-Free Cash Flow (P/FCF) Ratio
-7.88 -13.83 -14.31 -13.80 -28.67
Price-to-Operating Cash Flow Ratio
-7.98 -14.72 -15.10 -15.97 -34.57
Price-to-Earnings Growth (PEG) Ratio
-0.73 0.23 0.04 -0.03 >-0.01
Price-to-Fair Value
-3.54 -16.81 -6.22 -4.93 -3.06
Enterprise Value Multiple
-5.82 -15.05 -8.38 3.43 -2.15
Enterprise Value
420.84M 832.91M 816.22M 634.23M 1.12B
EV to EBITDA
-5.82 -15.05 -8.38 3.43 -2.15
EV to Sales
384.68 431.11 484.98 631.08 867.02
EV to Free Cash Flow
-9.34 -14.59 -14.66 -14.31 -28.92
EV to Operating Cash Flow
-9.45 -15.53 -15.47 -16.56 -34.88
Tangible Book Value Per Share
-0.07 -0.04 -0.13 -0.14 -0.50
Shareholders’ Equity Per Share
-0.07 -0.04 -0.13 -0.14 -0.50
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 -0.30 0.02 -0.02
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
-0.06 -0.06 -0.13 0.21 -0.74
Tax Burden
1.00 1.00 1.30 1.00 1.02
Interest Burden
1.11 1.10 1.06 0.97 1.02
Research & Development to Revenue
31.48 14.35 21.10 20.21 26.05
SG&A to Revenue
29.13 15.38 19.82 33.23 42.03
Stock-Based Compensation to Revenue
1.75 2.28 7.31 15.42 40.44
Income Quality
0.54 0.86 0.50 -0.21 0.06
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis